Benzinga
Benzinga
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Benzinga
sabato, ottobre 31
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
MDxHealth SA
MDXH
NASDAQ
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$0.1633
-0.0179
-9.88%
Ult. Agg.: Oct 30, 7:13 PM
Get Report
Panoramica
Notizie
Previsioni utili
Obiettivi di prezzo
Dati finanziari
Sentiment
Azionariato
Confronta
Rapporto azionario
Utili:
I risultati di Q3 2026 tra 12 giorni da adesso in gio nov 12th, dopo la chiusura del mercato
MDxHealth Financials
MDxHealth (MDXH) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
Dow Surges 250 Points; M&T Bank Posts Upbeat Q3 Earnings
U.S. stocks mixed: Dow +0.48%, Nasdaq -0.65%, S&P -0.05%. Energy rose, tech fell, and M&T Bank beat Q3 estimates; oil eased, gold gained.
Avi Kapoor
PRO
MDxHealth Suspends FY2026 Revenue Guidance Of $110M-$115M; Reports Preliminary Q3 Revenue Of About $22.7M vs. $22.7M Year Ago
Benzinga Newsdesk
MDxHealth Says Well-Positioned to 'Return to Positive EBITDA'
MDxHealth reports Q2 sales growth, mixed earnings and reaffirmed 2026 revenue guidance as tissue test volumes rise.
Vandana Singh
PRO
MDxHealth Affirms FY2026 Sales Guidance of $110.000M-$115.000M vs $98.814M Est
MDxHealth (NASDAQ:MDXH) affirms FY2026 sales outlook from $110.000 million-$115.000 million to $110.000 million-$115.000 million vs $98.814 million estimate.
Benzinga Newsdesk
PRO
MDxHealth Q2 EPS $(0.18) Misses $(0.16) Estimate, Sales $27.200M Beat $25.884M Estimate
MDxHealth (NASDAQ:MDXH) reported quarterly losses of $(0.18) per share which missed the analyst consensus estimate of $(0.16) by 12.5 percent. This is a 20 percent decrease over losses of $(0.15) per share from the same
Benzinga Newsdesk
PRO
MDxHealth Lowers FY2026 Sales Guidance from $137.000M-$140.000M to $110.000M-$115.000M vs $135.912M Est
MDxHealth (NASDAQ:MDXH) lowers FY2026 sales outlook from $137.000 million-$140.000 million to $110.000 million-$115.000 million vs $135.912 million estimate.
Benzinga Newsdesk
